Abstract
The vitamin D compounds all have the basic steroid ring structure. Splitting of one of the rings is brought about by ultraviolet light, a reaction which occurs in the skin (Holick et al. 1977; Esvelt et al. 1978), and previtamin D3 so formed from 7-dehydrocholesterol is equilibrated to vitamin D3 in the skin (Holick et al. 1977). Vitamin D3 (cholecalciferol) and its metabolites are the main naturally occurring compounds in man and animals, but vitamin D2 (ergocalci- ferol) and its metabolites are also present in man, because of fortification of the diet. Vitamin D3 is converted to 25-hydroxycholecalciferol (25-OH-D3) in the liver by means of a mitochondrial 25-hydroxylase (Bhattacharyya and DeLuca 1974; Olson et al. 1976; Madhok et al. 1978). Studies using tritiated 25-OH-D3 have demonstrated its further hydroxylation to 1,25- dihydroxyvitamin D3 (1,25(OH)2D3) (Cousins et al. 1970; Holick et al. 1971; Lawson et al. 1971), a process which occurs in the kidney, the necessary enzyme system being localised in the proximal tubules (Fraser and Kodicek 1970; Midgett et al. 1973; Brunette et al. 1978). Since l,25(OH)2D3 is an inhibitor of the renal 1-hydroxylase, there is a short-loop negative feedback control of the hydroxylation process (Larkins et al. 1974; Omdahl 1978; Omdahl and Hunsaker 1978; Henry 1979).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams P, Jowsey J (1967) Bone and mineral metabolism in hyperthyroidism: an experimental study. Endocrinology 81:735–740
Adams PH, Jowsey J, Kelly PJ, Riggs BL, Kinney VR, Jones JD (1967) Effects of hyperthyroidism on bone and mineral metabolism in man. Q J Med 36:1–15
Albright F, Burnett CH, Smith PH, Parson W (1942) Pseudo-hypoparathyroidism: example of ‘Seabright- bantam syndrome’: a report of three cases. Endocrinology 30:922–932
Albright F, Burnett CH, Parson W, Reifenstein FC, Roos A (1946) Osteomalacia and late rickets. Medicine (Baltimore) 25:399–479
Anderson J, Bannister DW, Parsons V, Tomlinson RWS (1967) Total urinary hydroxyproline in osteomalacia. Calcif Tissue Res 1:183–191
Ardaillon R (1975) Kidney and calcitonin. Nephron 15:250–260
Arnaud C, Rasmussen J, Anast C (1966) Further studies on the inter-relationship between parathyroid hormone and vitamin D. J Clin Invest 45:1955–1964
Arnaud SR, Goldsmith RS, Lambert RW, Go VLW (1975) 25 hydroxyvitamin D3: evidence of an entero- hepatic circulation in man. Proc Soc Exp Biol Med 149:570–572
Askanazy M, Rutishauser E (1933) Die Knochen der Basedow Kranken. Beitrag zur latenten Osteodystrophia fibrosa. Virchows Arch [A] 291:653–681
Austin LA, Heath H (1981) Calcitonin. Physiology and patho-physiology. N Engl J Med 304:269–278
Barzel US, Jowsey J (1969) The effect of chronic acid and alkali administration on bone turnover in adult rats. Clin Sci 36:517–524
Baylink D, Morey E, Rich C (1969) Effect of calcitonin on the rates of bone formation and resorption in the rat. Endocrinology 84:261–269
Beck N, Webster SK (1976) Effect of acute metabolic acidosis on parathyroid hormone action and calcium mobilization. Am J Physiol 230:127–131
Beighton P (1978) Inherited disorders of the skeleton. Churchill Livingstone, Edinburgh
Bell NH (1980) Vitamin D-dependent rickets type II. Calcif Tissue Int 31:89–91
Bhattacharyya M, DeLuca HF (1979) Subcellular localisation of rat liver calciferol-25-hydroxylase. Arch Biochem Biophys 160:58–62
Booth BE, Tsai HC, Morris ERC (1977) Parathyroidectomy reduces 25-hydroxyvitamin D3-l-hydroxylase activity in the hypocalcaemic vitamin D-deficient chick. J Clin Invest 60:1314–1320
Bordier P, Miravet L, Matrajt H, Hioco D, Ryckewaert A (1967) Bone changes in adult patients with abnormal thyroid function (with special reference to 45Ca kinetics and quantitative histology). Proc R Soc Med 60:1132–1134
Boris A, Hurkey JF, Trinal T, Mallon JP, Matuszewski DS (1979) Inhibition of diphosphonate-blocked bone mineralization. Evidence that calcitonin promotes mineralization. Acta Endocrinol (Copenh) 91:351–361
Bouillon R, De Moor P (1974) Parathyroid function in patients with hyper- and hypothyroidism. J Clin Endocrinol Metab 38:999–1004
Bouillon R, Muls E, De Moor P (1980) Influence of thyroid function on the serum concentration of 1,25- dihydroxyvitamin D3. J Clin Endocrinol Metab 51:793–797
Boyce BF, Elder HY, Fell GS, Nicholson WAP, Smith GD, Dempster DW, Gray CC, Boyle IT (1981) Quantitation and localisation of aluminium in human cancellous bone in renal osteodystrophy. Scan Electron Microsc III: 329–337
Boyce BF, Fell GS, Elder HY, Junar BJ, Elliot HL, Beastall G, Fogelman I, Boyle IT (1982) Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet II: 1009–1012
Bronsky D, Kushner DS, Dubin A, Snapper I (1958) Idiopathic hypoparathyroidism: case reports and review of the literature. Medicine (Baltimore) 37:317–352
Brooks MH, Bell NH, Love L, Stern PH, Orfei E, Queener SF, Hamstra AJ, DeLuca HF (1978) Vitamin D-dependent rickets type II. Resistance of target organs to 1,25-dihyroxy-vitamin D. N Engl J Med 298:996–999
Brumbaugh PF, Haussier MR (1975) Specific binding of 1 alpha, 25 dihydroxycholecalciferol to nuclear components to chick intestine. J Biol Chem 250:1588–1595
Brunette MG, Chan M, Ferriere C, Roberts KO (1978) Site of 1,25-dihydroxyvitamin D3 synthesis in the kidney. Nature 276:287–289
Byers PD, Smith R (1971) Quantitative histology of bone in hyperparathyroidism. Its relation to clinical features, X-ray and biochemistry. Q J Med 40:471–486
Campos C, Arata RO, Mautalen CA (1976) Parathyroid hormone and vertebral osteosclerosis in uraemic patients. Metabolism 25:495–501
Castro JH, Genuth SM, Klein L (1975) Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism. Metabolism 24:840–848
Chalmers J (1968) Osteomalacia. J R Coll Surg Edinb 13:255–275
Chambers TJ, Magnus CJ (1982) Calcitonin alters behaviour of isolated osteoclasts. J Pathol 136:27–39
Chase LR, Melsen GL, Aurbach GD (1969) Pseudohypoparathyroidism: defective excretion of 3´5´-AMP in response to parathyroid hormone. J Clin Invest 48:1832–1844
Chen TC, DeLuca HF (1973) Receptors of 1,25 dihydroxycholecalciferol in rat intestine. J Biol Chem 248:4890–4895
Chen TC, Hirst MA, Feldman D (1979) A receptor-like binding macromolecule of 1α21 dihydroxycholecalciferol in cultured mouse bone cells. J Biol Chem 254:7491–7494
Choufoer JH, Steendijk R (1979) Distribution of the perilacunar hypomineralized areas in cortical bone from patients with familial hypophosphatemic (vitamin D-resistant) rickets. Calcif Tissue Int 27:101–104
Clark OH, Taylor S (1972) Osteoclastoma of the jaw and multiple parathyroid tumors. Surg Gynecol Obstet 135:188–192
Coburn JW, Hartenbower DL, Birchman AS (1976) Advances in vitamin D metabolism as they pertain to chronic renal disease. Am J Clin Nutr 29:1283–1299
Collins DH (1966) Pathology of bone. London, Butterworths
Colodro IH, Brickman AS, Coburn JW, Osborn TW, Norman AW (1978) Effect of 25-hydroxyvitamin D3 on intestinal absorption in normal man and patients with renal failure. Metabolism 27:745–753
Compston JE, Creamer B (1977) Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut 18:171–175
Compston JE, Thompson RPH (1977) Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet II: 721–724
Cook PB, Nassim JR, Collins J (1959) The effects of thyrotoxicosis upon the metabolism of calcium, phosphorus and nitrogen. Q J Med 28:505–529
Cournot-Witmer G, Plachot JJ, Lefevre R, Bourdon R, Galle P, Drueke T, Balsan S (1980) Aluminium in bone from haemodialysed patients: relationship to bone histology and localization by electron microprobe and secondary ion microscopy. Metab Bone Dis Relat Res 25:491
Courpron P, Meunier P, Bressot C, Giroux JM (1976) Amount of bone in iliac crest biopsy. Significance of the trabecular bone volume. Its values in normal and in pathological conditions. In: Meunier PJ (ed) Bone histomorphometry. 2nd international workshop. Armour Montagu, Paris, pp 39–53
Cousins RJ, DeLuca HF (1972) Vitamin D and bone. In: Bourne GH (ed) The biochemistry and physiology of bone, 2nd edn, Vol 2 Physiology and pathology. Academic, New York, pp 282–335
Cousins RJ, DeLuca HF, Gray RW (1970) Metabolism of 25-hydroxycholecalciferol in target and nontarget tissues. Biochemistry 9:3649–3652
Cowgill LD, Goldfarb S, Lau K, Slatopolsky E, Agus ZS (1979) Evidence for an intrinsic renal tubular defect in mice with genetic hypophosphatemic rickets. J Clin Invest 63:1203–1210
Cunningham J, Fraher LJ, Clemens TL, Revell PA, Papapoulos SE (1982) Chronic acidosis with metabolic bone disease. Effect of alkali on bone morphology and vitamin D metabolism. Am J Med 73:199–204
Dalen M, Hjern B (1974) Bone mineral content in patients with primary hyperparathyroidism without radiological evidence of skeletal changes. Acta Endocrinol (Copenh) 75:297–304
Danovitch SH, Baer PN, Laster L (1968) Intestinal alkaline phosphatase activity in familial hypophosphatasia. N Engl J Med 278:1253–1260
Deftos LJ, Weisman MH, Williams GW, Karpf DB, Frumar AM, Davidson BJ, Pothenmore JG, Judd HL (1980) Influence of age and sex on plasma calcitonin in human beings. N Engl J Med 302:1351–1353
Delling GR, Schultz A (1977) Bone cells and remodelling surfaces in acromegaly. Calcif Tissue Res (Suppl) 22:255–259
DeLuca HF (1978) Vitamin D metabolism and function. Arch Intern Med 138:836–847
DeLuca HF (1979) The vitamin D system in the regulation of calcium and phosphorous metabolism. Nutr Rev 37:161–193
Dent CE (1970) Rickets (and osteomalacia), nutritional and metabolic. Proc R Soc Med 63:401–408
Dent CE, Harris H (1956) Hereditary forms of rickets and osteomalacia. J Bone Joint Surg [Br] 38:204–226
Dent CE, Smith R (1969) Nutritional osteomalacia. Q J Med 38:195–209
Dent CE, Stamp JCB (1971) Hypophosphataemic osteomalacia presenting in adults. Q J Med 40:303–329
Drezner MK, Neelon FA, Haussier M, McPherson HT, Lebovitz HE (1973a) 1,25-dihydroxycholecalciferol deficiency: the probable cause of hypercalcaemia and metabolic bone disease in pseudohypoparathyroidism. J Clin Endocrinol Metab 42:621–628
Drezner MK, Neelon FA, Lebovitz HE (1973b) Pseudohypoparathyroidism type II. A possible defect in the reception of the cyclic AMP signal. N Engl J Med 289:1056–1060
Drezner MK, Neelon FA, Jowsey J, Lebovitz HE (1977) Hypoparathyroidism: a possible cause of osteomalacia. J Clin Endocrinol Metab 45:114–122
Eastwood JB (1982) Quantitative bone histology in 38 patients with advanced renal failure. J Clin Pathol 35:125–134
Eddy RL (1971) Metabolic bone disease after gastrectomy. Am J Med 50:442–449
Ellis HA, Peart KM (1973) Azotaemic renal osteodystrophy: a quantitative study on iliac bone. J Clin Pathol 26:83–101
Ellis HA, McCarthy JH, Herrington J (1979) Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation. J Clin Pathol 32:832–844
Engfeldt B, Zetterstrom R, Winberg T (1956) Primary vitamin D resistant rickets. III Biophysical studies of skeletal tissue. J Bone Joint Surg [Am] 38:1323–1334
Erdheim J (1931) Über Wirbelsäutenweränderungen bei Akromegalie. Virchows Arch [A] 281:197–296
Esvelt RP, Schnoes HK, DeLuca HF (1978) Vitamin D3 from rat skins irradiated in vitro with ultraviolet light. Arch Biochem Biophys 188:282–286
Evans DJ, Azzopardi JG (1972) Distinctive tumours of bone and soft tissue causing acquired vitamin D resistant osteomalacia. Lancet I:353
Faccini JM, Teotia SP (1974) Histopathological assessment of endemic skeletal fluorosis. Calcif Tissue Res 16:45–57
Felton DJC, Stone WD (1966) Osteomalacia in Asian immigrants during pregnancy. Br Med J 1:1521–1522
Follis RH (1953) Skeletal changes associated with hyperthyroidism. Bull John Hopkins Hosp 92:405–421
Forland M, Strandjord NM, Paloyan E, Cox A (1968) Bone density studies in primary hyperparathyroidism. Arch Intern Med 122:236–240
Foster GV, MacIntyre I, Pease AGE (1963) Calcitonin production and the mitochondrion-rich cells of the dog thyroid. Nature 203:1029–1030
Frame B, Durham RH (1959) Simultaneous hyperthyroidism and hyperparathyroidism. Am J Med 27:824–828
Frame B, Parfitt AM (1978) Osteomalacia: current concepts. Ann Intern Med 89:966–982
Frame B, Hanson CA, Frost HM, Block M, Arnstein AR (1972) Renal resistance to parathyroid hormone with osteitis fibrosa: “pseudohypoparathyroidism”. Am J Med 52:311–321
Fraser D (1957) Hypophosphatasia. Am J Med 22:730–746
Fraser DR, Kodicek E (1970) Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature 228:764–766
Fraser DR, Kodicek E (1973) Regulation of 25-hydroxycholecalciferol-l-hydroxylase activity in the kidney by parathyroid hormone. Nature 241:163–166
Fraser D, Koch SW, Kind HP, Holick MF, Tanaka Y, DeLuca HF (1973) Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. N Engl J Med 289:817–824
Freitag J, Martin KJ, Hruska KA, Anderson C, Conrades M, Ladenson J, Klahr S, Slatopolsky E (1978) Impaired parathyroid hormone metabolism in patients with chronic renal failure. N Engl J Med 298:29–32
Frost HM (1963) A unique histological feature of vitamin D resistant rickets observed in four cases. Acta Orthop Scand 33:220–226
Frost HM, Griffith DL, Jee WSS, Kimmel DB, McCandlis RP, Teitelbaum SL (1981) Histomorphometric changes in trabecular bone of renal failure patients treated with calcifediol. Metab Bone Dis Relat Res 2:285–293
Frymoyer JW, Hodgkin W (1977) Adult-onset vitamin D-resistant hypophosphatemic rickets. J Bone Joint Surg [Am] 59:101
Garabedian M, Holick MF, DeLuca HF, Boyle IT (1972) Control of 25-hydrocholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci USA 69:1673–1676
Garrick R, Ireland AW, Posen S (1971) Bone abnormalities after gastric surgery. Ann Intern Med 75:221–225
Genant HK, Baron JM, Straus FH, Paloyan E, Jowsey J (1975) Osteosclerosis in primary hyperparathyroidism. Am J Med 59:104–113
Glorieux F, Scriver CR (1972) Loss of a parathyroid hormone-sensitive component of phosphate transport in X-linked hypophosphatemia. Science 175.997–1000
Glorieux FH, Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol and calcitrol in hypophosphatemie vitamin D-resistant rickets. N Engl J Med 303:1023–1031
Goldfischer S, Johnson A, Morecki R (1976) Hypophosphatasia. A cytochemical study of phosphate activities. Lab Invest 35:55–62
Gray TK, Brannan P, Juan D, Morawski SG, Fordtran JS (1976) Ion transport changes during calcitonin-induced intestinal secretion in man. Gastroenterology 71:392–398
Haas HG, Dambacher MA, Guncaga J, Lauffenburger T (1971) Renal effects of calcitonin and parathyroid hormone extract in man. J Clin Invest 50:2689–2702
Haldimann B, Kaptein EM, Singer FR, Nicoloff JT, Massry SG (1980) Intestinal absorption in patients with hyperthyroidism. J Clin Endocrinol Metab 51:995–997
Harris HA (1926) The growth of the long bones in childhood, with special reference to certain bony striations of the metaphysis and to the role of vitamins. Arch Intern Med 38:785–806
Haussier MR, Baylink DJ, Hughes MR (1976) The assay of la, 25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol 5:151S-165S
Heath H III, Sizemore GW (1977) Plasma calcitonin in normal man: differences between men and women. J Clin Invest 60:1135–1140
Heersche JNM, Marcus R, Aurbach GD (1974) Calcitonin and the formation of 3´5´-AMP in bone and kidney. Endocrinology 94:241–247
Henry HL (1979) Regulation of hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells. J Biol Chem 254:2722–2729
Henry HL, Midgett RJ, Norman AW (1974) Regulation of 25-hydroxyvitamin D3-l-hydroxylase in vivo. J Biol Chem 249:7584–7592
Hepner GW, Roginsky M, Moo HF (1976) Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis 21:527–532
High WB, Capen CC, Black HE (1981) Effects of thyroxine on cortical bone remodeling in adult dogs. A histomorphometric study. Am J Pathol 102:438–446
Hillman LS, Haddad JG (1975) Perinatal vitamin D metabolism. II serial 25-hydroxyvitamin D concentrations in the sera of term and premature infants. J Pediatr 86.928–935
Hodkinson HM, Stanton BR, Round P, Morgan C (1973) Sunlight, vitamin D and osteomalacia in the elderly. Lancet I:910–912
Holick MF, Schnoes HK, DeLuca HF (1971) Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci USA 68:803–804
Holick MF, Frommer J, McNeill S, Richt N, Henley J, Potts JT (1977) Photometabolism of 7- dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun 76:107–114
Holtrop ME, Raisz LG (1979) Comparison of the effects of 1,25-dihydroxycholecalciferol, prostaglandin E2 and osteoclast-activity factor with parathyroid hormone on the ultrastructure of osteoclasts in cultured long bones of fetal rats. Calcified Tissue Int 29:201–205
Holtrop ME, Raisz LG, Simmons HA (1974) The effects of parathyroid hormone, colchicine and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture. J Cell Biol 60:346–355
Hough S, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL (1981) Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. Endocrinology 108:2228–2234
Howard G, Baylink D (1980) Matrix formation and osteoid maturation in vitamin D-deficient rats made normocalcaemic by dietary means. Miner Electrolyte Metab 3:44–50
Howe PR, Wesson LG, Boyle PE, Wolbach SD (1940) Low calcium rickets in the guinea pig. Proc Soc Exp Biol Med 45:298–301
Jaffe HL (1972) Metabolic, degenerative and inflammatory diseases of bones and joints. Lea and Febiger, Philadelphia
Jimenea CV, Frame B, Chaykin LB, Sigler JW (1971) Spondylitis of hypoparathyroidism. Clin Orthop 74:84–89
Jowsey J, Detenbeck LC (1969) Importance of thyroid hormones in bone metabolism and calcium homeostasis. Endocrinology 85:87–95
Jowsey J, Riggs BL, Kelly PJ, Hoffman DL, Bordier PH (1971) The treatment of osteoporosis with disodium ethane-1-hydroxyl-1,1-diphosphonate. J Lab Clin Med 78:574–584
Jowsey J, Riggs BL, Kelly PJ, Hoffman DL (1972) Effects of combined therapy with sodium fluoride, calcium, vitamin D on the lumbar spine in osteoporosis. Am J Med 53:43–49
Kallio DM, Garant PR, Minkin C (1972) Ultrastructural effects of calcitonin on osteoclasts in tissue culture. J Ultrastruct Res 39:205–216
Kinard RE, Walton JE, Buckwalter JA (1979) Pseudohypoparathyroidism. Report on a family with four affected sisters. Arch Intern Med 139:204–207
King GJ, Holtrop ME, Raisz LG (1978) The relation of ultrastructural changes in osteoclasts to resorption in bone cultures stimulated with parathyroid hormone. Metab Bone Dis Relat Res 1:67–72
Knop J, Mantz R, Schneider C, Striktzke P, Dorn-Quint G, Nordmeyer JP, Kruse HP, Kohlencordt F (1980) Bone calcium exchange in primary hyperparathyroidism as measured by 47calcium kenetics. Metabolism 29:819–825
Krane SM, Harrie ED, Singer FR, Potts JT (1973) Acute effects of calcitonin on bone formation in man. Metabolism 22:51–58
Kream BE, Jose M, Yamada S, DeLuca HF (1977) A specific high affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone. Science 197:1086–1088
Lancet (1977) Hepatic osteodystrophy. Lancet I:988 (editorial)
Larkins RG, MacAuley SJ, MacIntyre I (1974) Feedback control of vitamin D metabolism by a nuclear action of 1,25-dihydroxycholecalciferol on the kidney. Nature 252:412–413
Lawson DEM, Fraser DR, Kodicek E, Morris HR, Williams DH (1971) Identification of 1,25- dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 230:228–230
Lawson DEM, Wilson PW (1979) Intranuclear localization and receptor proteins for 1,25- dihydroxycholecalciferol in chick intestine. Biochem J 144:573–592
Lee JB, Tashjian AH, Streeto JM, Fratz AG (1968) Familial pseudohypoparathyroidism. Role of parathyroid hormone and thyrocalcitonin. N Engl J Med 279:1179–1184
Lekkerkerker JFF, Doorenbos H (1973) The influence of thyroid hormone on calcium absorption from the gut in relation to urinary calcium excretion. Acta Endocrinol (Copenh) 73:672–680
Lemann J, Litzow JR, Lennon EJ (1966) The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 45:1608–1614
Levin ME, Boisseau VC, Avioli LV (1976) Effects of diabetes mellitus on bone mass in juvenile and adult- onset diabetes. N Engl J Med 294:241–245
Lewin IG, Papapoulos SE, Tomlinson S, Hendy GN, O’Riordan JLH (1978) Studies of hypoparathyroidism and pseudohypoparathyroidism. Q J Med 47:533–548
Liberman UA, Halabe A, Samuel R, Kauli R, Edelstein S, Weisman Y, Papapoulos SE, Fraher LJ, Clemens TL, O’Riordon JLH (1980) End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet I:504–506
Long RG, Shiver RD, Wills MR, Sherlock S (1976) Serum 25-dihydroxyvitamin D in untreated parenchymal and cholestatic liver disease. Lancet II: 650–652
Lotz M, Zisman E, Bartter FC (1968) Evidence for a phosphorus depletion syndrome in man. N Engl J Med 278:409–414
Lund Bj, Sorenson OH, Lund Bi, Bishop JE, Norman AW (1980) Vitamin D metabolism in hypoparathyroidism. J Clin Endocrinol Metab 51:606–610
Lyles KW, Berry WR, Haussier M, Harrelson JM, Drezner MK (1980) Hypophosphatemic osteomalacia: association with prostatic carcinoma. Ann Intern Med 93:275–278
Mann JB, Alterman S, Hills SG (1962) Albright’s hereditary osteodystrophy, comprising pseudohypoparathyroidism and pseudo-pseudohypoparathyroidism, with a report of two cases representing the complete syndrome occurring in successive generations. Ann Intern Med 56:315–342
Marie PJ, Glorieux FH (1981) Histomorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets. Metab Bone Dis Relat Res 3:31–38
Marie PJ, Travers R, Glorieux FH (1981) Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse. J Clin Invest 67:911–914
Marx SJ, Spiegel AM, Brown EM, Gardner DG, Downs RW Jr, Attie M, Hamstra AJ, DeLuca HF (1978) A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 47:1303–1310
Massry SG, Ritz E (1978) The pathogenesis of secondary hyperparathyroidism of renal failure. Is there a controversy? Arch Intern Med 138:853–856
Mautalen C, Montoreano R, Labarrere C (1976) Early skeletal effect of alkali therapy upon the osteomalacia of renal tubular acidosis. J Clin Endocrinol Metab 42:875–881
Maxon HR, Apple DJ, Goldsmith RE (1978) Hypercalcaemia in thyrotoxicosis. Surg Gynecol Obstet 147:694–696
McFarlane JD, Lutkin JE, Burwood MA (1977) The demonstration by scintography of fractures in osteomalacia. Br J Radiol 50:369–371
McMillan PJ, Hooker WM, Deftos LJ (1974) Distribution of calcitonin-containing cells in the human thyroid gland. Am J Anat 140:73–79
McNair P, Madsbad S, Christiansen C, Faber OK, Transbol I, Binder C (1978) Osteopenia in insulin treated diabetes mellitus. Its relation to age at onset, sex and duration of disease. Diabetologia 15:87–90
McSherry E, Morris RC (1978) Attainment and maintenance of normal stature with alkali therapy in infants and children with classical renal tubular acidosis. J Clin Invest 61:509–527
Mellow AM, Stosich GV, Stern PH (1978) Dissociation of specific binding of 25-OH-D3 and resorption in fetal rat bones. Mol Cell Endocrinol 10:149–158
Melsen F, Mosekilde L (1978) Dynamic studies of trabecular bone formation and osteoid maturation in normal and certain pathological conditions. Metab Bone Dis Relat Res 1:45–48
Melsen F, Mosekilde L (1980) Trabecular bone mineralisation lag time determined by tetracycline doublelabelling in normal and certain pathological conditions. Acta Pathol Microbiol Immunol Scand [A] 88:83–88
Melvin KEW, Hepner GW, Bordier P, Neale G, Joplin GF (1970) Calcium metabolism and bone pathology in adult coeliac disease. Q J Med 39:83–113
Metz SA, Baylink DJ, Hughes MR, Haussier MR, Robertson RP (1977) Selective deficiency of 1,25- dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone. N Engl J Med 297:1084–1090
Meunier P, Edouard C, Richard D, Laurent J (1976) Histomorphometry of osteoid tissue. The hyperosteoidoses. In: Meunier PJ (ed) Bone histomorphometry. 2nd international workshop. Armour Montagu, Paris. pp 249–262
Meyer RA, Gray RW, Meyer MH (1980) Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. Endocrinology 107:1577–1581
Midgett RJ, Spielvogel AM, Coburn JW, Norman AW (1973) Studies on calciferol metabolism. VII The renal production of the biologically active form of vitamin D, 1,25-dihydroxycholecalciferol; species, tissue and subcellular distribution. J Clin Endocrinol Metab 36:1153–1161
Mosekilde L, Melsen F (1978) A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Med Scand 204:97–102
Mosekilde L, Melsen F, Bagger JP, Myrhe-Jensen O, Sorenson NS (1977) Bone changes in hyperthyroidism: inter-relationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol (Copenh) 85:515–525
Moses AM, Rao KJ, Coulson R, Miller M (1974) Parathyroid hormone deficiency with Albright’s hereditary osteodystrophy. J Clin Endocrinol Metab 39:496–500
Moss AJ, Waterhouse, C, Terry R (1965) Gluten-sensitive enteropathy with osteomalacia but without steatorrhoea. N Engl J Med 272:825–830
Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG (1976) Direct stimulation of bone resorption by thyroid hormones. J Clin Invest 58:529–534
Nusynowitz ML, Klein MH (1973) Pseudoidiopathic hypoparathyroidism. Hypoparathyroidism with ineffective parathyroid hormone. Am J Med 55:677–686
Olson EB, Knutson JC, Bhattacharyya MH, DeLuca HF (1976) Effect of hepatectomy on synthesis of 25 hydroxyvitamin-D3. J Clin Invest 57:1213–1220
Omdahl JL (1978) Interaction of the parathyroid and 1,25-dihydroxyvitamin D3 in the control of renal 25-hydroxyvitamin D3 metabolism. J Biol Chem 253:8474–8478
Omdahl JL, Hunsaker LA (1978) Direct modulation of 25-hydroxyvitamin D3 hydroxylation in kidney tubules by 1,25-dihydroxyvitamin D3. Biochem Biophys Res Commun 81:1073–1079
Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ (1982) The prevalence of bone aluminium deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 307:709–713
Palma FJM, Ellis HA, Cook DB, Dewar JH, Ward MK, Wilkinson R, Kerr DNS (1983) Osteomalacia in patients with chronic renal failure before dialysis or transplantation. Q J Med 52:332–348
Parfitt AM (1972a) The spectrum of hypoparathyroidism. J Clin Endocrinol Metab 34:152–158
Parfitt AM (1972b) Hypophosphatemic rickets and osteomalacia. Orthop Clin North Am 3:653–680
Parfitt AM, Dent CE (1970) Hyperthyroidism and hypercalcaemia. Q J Med 39:171–187
Parfitt AM, Miller MJ, Frame B, Villanueva AR, Rao DS, Oliver I, Thomson DL (1978) Metabolic bone disease after intestinal by-pass for treatment of obesity. Ann Intern Med 89:193–199
Pavlovitch H, Presle V, Balsani S (1977) Decreased bone sensitivity of thyroidectomized rats to the cal- caemia effects of 1,25-dihydroxycholecalciferol. Acta Endocrinol (Copenh) 84:774–779
Perry W, Stamp TCB (1978) Hereditary hypophosphataemic rickets with autosomal recessive inheritance and severe osteosclerosis. J Bone Joint Surg [Br] 60:430–434
Perry W, Allen LN, Stamp TCB, Walker PG (1977) Vitamin D resistance in osteomalacia after ureterosig- moidostomy. N Engl J Med 297:1110–1112
Pierides AM, Ellis HA, Ward M, Simpson W, Peart KM, Alvares-Ude F, Uldall PR, Kerr DNS (1976) Barbiturate and anticonvulsant treatment in relation to osteomalacia with haemodialysis and renal transplantation. Br Med J I:190–193
Pierides AM, Skillen AW, Ellis HA (1979) Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology and their changes in response to treatment with 10HD3 and l,25(OH)2D3. J Lab Clin Med 93:899–909
Pimstone B, Eisenberg E, Silverman S (1966) Hypophosphatasia: genetic and dental studies. Ann Intern Med 65:722–729
Pines KL, Mudge GH (1951) Renal tubular acidosis with osteomalacia. Am J Med 11:302–322
Potts JT (1983) Calcium metabolism. In: Osteoporosis. A multidisciplinary problem. Royal Society of Medicine International Congress and Symposium Series No 55. Academic Press and Royal Society of Medicine, London, pp 3–18
Preece MA, Tomlinson S, Ribot CA, Pietrek J, Korn HT, Davies DM, Ford JA, Dunnigan MG, O’Riordan JLH (1975) Studies of vitamin D deficiency in man. Q J Med 44:575–580
Prost A, Hanniche M, Bordier P, Miravet L, DeSeze S, Rambaud JC (1975) Osteomalacia in chronic pancreatitis. Nouv Presse Med 4:1561–1566
Purnell DC, Smith LH, Scholz DA, Elveback LR, Arnaud CD (1971) Primary hyperparathyroidism. A prospective clinical study. Am J Med 50:670–678
Purnell DC, Scholz DA, Smith LH, Sizemore GH, Black BM, Goldsmith RS, Arnaud CD (1974) Treatment of primary hyperparathyroidism. Am J Med 56:800–809
Raisz LG, Kream BE (1983a) Regulation of bone formation. N Engl J Med 309:29–35
Raisz LG, Kream BE (1983b) Regulation of bone formation. N Engl J Med 309:83–89
Ramser JR, Frost H, Smith R (1966) Tetracycline-based measurement of the tissue and cell dynamics in rib of a 25 year old man with active acromegaly. Clin Orthop 49:151–162
Rathbun JC, MacDonald JW, Robinson HMC, Wanklin JM (1961) Hypophosphatasia: a genetic study. Arch Dis Child 36:540–542
Reinhart R, Brickman AS, Kurokawa K, Coburn JW, Massry SG (1973) Studies in three generations of a kindred with pseudohypoparathyroidism. Clin Res 21:255–261
Reiss E, Canterbury JM (1971) Genesis of hyperparathyroidism. Am J Med 50:679–685
Richards P, Chamberlain MJ, Wrong OM (1972) Treatment of osteomalacia of renal tubular acidosis by sodium bicarbonate. Lancet II: 994–997
Riggs BL, Randall RV, Wahner HW, Jowsey J, Kelly PJ, Singh M (1972) The nature of the metabolic bone disorder in acromegaly. J Clin Endocrinol Metab 34:911–918
Rodbell M (1980) The role of hormone receptors and GTP regulatory proteins in membrane transduction. Nature 284:17–22
Ross EM, Gilman AG (1980) Biochemical properties of hormone sensitive adenylate cyclase. Annu Rev Biochem 49:533–564
Rutherford WE, Blendin J, Hruska K (1975) Effect of 25 hydroxycholecalciferol on calcium absorption in chronic renal disease. Kidney Int 8:320–324
Rutherford WE, Bordier P, Marie P, Hruska K, Harter H, Greenwalt A, Blondin J, Haddad J, Bricker N, Slatopolsky E (1977) Phosphate control and 25 hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog. J Clin Invest 60:332–341
Salassa RM, Jowsey J, Arnaud CD (1970) Hypophosphatemic osteomalacia associated with non-endocrine tumours. N Engl J Med 283:65–70
Scriver CR (1974) Rickets and the pathogenesis of impaired tubular transport of phosphate and other solutes. Am J Med 57:43–49
Sherwood LH, Mayer GP, Ramberg CF, Kronfeld DS, Aurbach GD, Potts JT (1968) Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology 83:1043–1051
Sherwood LM, Herrman I, Bassett CA (1970) Parathyroid hormone secretion in vitro: regulation by calcium and magnesium ions. Nature 225:1056–1058
Shipley PG, Park EA, McCollum EV, Simmons N (1921) Studies on experimental rickets. III A pathological condition bearing fundamental resemblances to rickets of the human being resulting from diets low in phosphorus and fat soluble A. The phosphate ion in its prevention. Bull Johns Hopkins Hosp 32:160–166
Shires R, Teitelbaum SL, Bergfeld MA, Fallon MD, Slatopolsky E, Avioli LB (1981) The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. J Lab Clin Med 97:231–240
Shohl AT (1936) Rickets in rats. XV. The effect of low calcium-high phosphorus diets at various levels and ratios upon the production of rickets and tetany. J Nutr 11:275–291
Silva OL, Wisneski LA, Cyrus J, Snider RH, Moore CF, Becker KL (1978) Calcitonin in thyroidectomised patients. Am J Med Sci 275:159–164
Silverman JL (1962) Apparent dominant inheritance of hypophosphatasia. Arch Intern Med 110:191–198
Sinha TK, DeLuca HF, Bell NH (1977) Evidence for a defect in the formation of 1,25 dihydroxyvitamin D in pseudohypoparathyroidism. Metabolism 26:731–738
Sitrin M, Meredith S, Rosenberg IH (1978) Vitamin D deficiency and bone disease in gastrointestinal disorders. Arch Intern Med 138:886–888
Skinner RK, Long RG, Sherlock S (1977) 25-hydroxylation of vitamin D in primary biliary cirrhosis. Lancet I:720–721
Slatopolsky E, Calgar S, Pennell JP, Taggart DD, Canterbury JM, Reiss E, Bricker NS (1971) On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 50:492–499
Slatopolsky E, Rutherford E, Hruska K, Martin K, Klahr S (1978) How important is phosphate in the pathogenesis of renal osteodystrophy? Arch Intern Med 138:848–851
Smith PS, McClure J (1982) Localisation of aluminium by histochemical and electron probe microanalytical techniques in bone tissues of cases of renal osteodystrophy. J Clin Pathol 35:1283–1293
Stanbury SW, Lumb GA (1962) Metabolic studies of renal osteodystrophy. 1. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome. Medicine (Baltimore) 41:1–34
Steinbach HL, Young DA (1966) The roentgen appearance of pseudohyperparathyroidism (PH) and pseudohypoparathyroidism (PPH). Differentiation from other syndromes associated with short metacarpals, metatarsals and phalanges. Am J Roentgenol Radium Ther Nucl Med 97:49–66
Stern PH (1980) The D vitamins and bone. Pharmacol Rev 32:47–80
Strom L, Winberg J (1954) Idiopathic hypoparathyroidism. Acta Paediatr Scand 43:574–581
Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF (1979) Target cells for 1,25 dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 206 :1188–1190
Taylor CM, Hughes SE, de Silva P (1976) Competitive protein binding assay for 24,25 dihydroxy-cholecalciferol. Biochem Biophys Res Commun 70:1243–1249
Teitelbaum SL, Halverson JD, Bates BS (1977) Abnormalities of circulatory 25-OH vitamin D after jejunal-ileal bypass for obesity. Ann Intern Med 86:289–293
Teitelbaum SL, Bergfeld MA, Freitag J, Hruska KA, Slatopolsky E (1980) Do parathyroid hormone and 1,25-dihydroxyvitamin D modulate bone formation in uremia? J Clin Endocrinol Metab 51:247–251
Thompson ER, Baylink DJ, Wergedahl JE (1975) Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat. Endocrinology 97:283–289
Tougaard L, Hau C, Rodbro P, Kitzel J (1977) Bone mineralization and bone mineral content in primary hyperparathyroidism. Acta Endocrinol (Copenh) 84:314–319
Tregear GW, Van Rietschoten J, Greene E, Kentmann HT, Niall HD, Reit B, Parsons JA, Potts JT (1973) Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity. Endocrinology 93:1349–1353
Tsuchiya Y, Matsuo N, Cho H, Kumagai M, Yasaka A, Suda T, Orimo H, Shiraki M (1980) An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D. J Clin Endocrinol Metab 51:685–690
Urist MR (1972) Growth hormone and skeletal tissue metabolism. In: Bourne GH (ed) The biochemistry and physiology of bone, 2nd edn. Vol 2 Physiology and pathology. Academic, New York, pp 155–195
Wagonfeld JB, Nemchausky BA, Bolt M (1976) Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis. Lancet II: 391–394
Warshawsky H, Goltzman D, Rouleau MF, Bergeron JJM (1980) Direct in vivo demonstration by autoradiography of specific binding sites for calcitonin in skeletal and renal tissues of the rat. J Cell Biol 85:682–694
Weber JC, Pons U, Kodicek E (1971) The localization of 1,25 dihydroxycholecalciferol in bone cell nuclei of rachitic chicks. Biochem J 125:147–153
Weinberg AG, Stone RT (1972) Autosomal dominant inheritance in Albright’s hereditary osteodystrophy. J Pediatr Scand 79:996–999
Weinberg SG, Lubin A, Wiener SN, Deoras MP, Ghose MK, Kopelman RC (1977) Myelofibrosis and renal osteodystrophy. Am J Med 63:755–764
Weinman JP, Schour I (1945) Experimental studies in calcification III. The effect of parathyroid hormone on the alveolar bone and teeth of the normal and rachitic rat. Am J Pathol 21:857–875
Weinstein RS, Whyte MP (1981) Heterogeneity of adult hypophosphatasia. Report of severe and mild cases. Arch Intern Med 141:727–731
Wergedal JE, Baylink DJ (1971) Factors affecting bone enzymatic activity in vitamin D-deficient rats. Am J Physiol 220:406–409
Wezeman F (1976) 25 hydroxyvitamin D3. Autoradiographic evidence of sites of action in epiphyseal cartilage and bone. Science 194:1069–1071
Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli LV (1979) Adult hypophosphatasia, clinical, laboratory and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore) 58:329–347
Wilkins L (1941) Epiphyseal dysgenesis associated with hypothyroidism. Am J Dis Child 61:13–20
Wills MR, Phillips JB, Day RC, Bateman EC (1972) Phytic acid and nutritional rickets in immigrants. Lancet I:771–773
Winters RW, Graham JB, Williams TF, McFalls VW, Burnett CH (1958) A genetic study of familial hyperphosphatemic and vitamin D-resistant rickets with a review of the literature. Medicine (Baltimore) 37:97–142
Wolfe HJ, Voelkel EF, Tashjian AH Jr (1974) Distribution of calcitonin-containing cells in the normal adult human thyroid gland: a correlation of morphology with peptide content. J Clin Endocrinol Metab 38:688–705
Woods CG (1966) Histological studies in osteomalacia. J Bone Joint Surg [Br] 48:188 (abstr)
Yu JS, Walker-Smith JA, Burnard ED (1971) Rickets, a common complication of neonatal hepatitis. Med J Aust 1:790–792
Zerwekh JE, Glass K, Jowsey J, Pak CYC (1979) A unique form of osteomalacia associated with end organ refractoriness to 1,25 dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab 49:171–175
Zile M, Bunge EC, Barsness L, Yamada S, Schnoes HK, DeLuca HF (1978) Localization of 1,25 dihydroxyvitamin D3 in intestinal nuclei in vivo. Arch Biochem Biophys 186:15–24
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Revell, P.A. (1986). Metabolic Bone Disease. In: Pathology of Bone. Springer, London. https://doi.org/10.1007/978-1-4471-1377-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1377-5_5
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1379-9
Online ISBN: 978-1-4471-1377-5
eBook Packages: Springer Book Archive